Oramed provides doses to patients across multiple sites
Oramed Pharmaceuticals Inc has announced that randomization of patients in its first Phase 3 study of its oral insulin capsule ORMD-0801 for the treatment...
Lupus Research Awards 2023 announced
The Lupus Research Alliance (LRA) announced the recipients of the newest Lupus Innovation Award (LIA) grants.
Collectively, the seven projects led by research teams from the U.S. and Europe explore multiple...
Covid-19: Treatments for people with early infection need urgent research focus
A JAMA Viewpoint article by National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony S. Fauci, M.D., and colleagues says Covid-19 treatments for...
SK Biopharmaceuticals, LifeSci Venture Partners announce partnership for Open Innovation
Innovative pharma company SK Biopharmaceuticals, Co., Ltd., has inked a pact with global life science venture capital firm LifeSci Venture Partners to collaborate on...
Adolescents’ sleep loss linked to neighbourhood conditions
Adolescents' loss of sleep is linked to conditions in the neighbourhood, according to the findings of a new study.
The study which has been published...
NeuroRx starts Phase 2/3 study of inhaled ZYESAMI
NeuroRx, Inc. has announced initiation of a Phase 2/3 clinical trial investigating the role of inhaled ZYESAMI (aviptadil).
The trial is being done for the...
Ampio says its study on Covid-19 patients proceeding to full open enrollment
Ampio Pharmaceuticals Inc has announced that its AP-014 Phase I inhaled Ampion clinical study in Covid-19 patients is proceeding to full open enrollment after...
Surprising lack of association between stress and migraine revealed
Surprising it might sound, but a new study has found lack of association between stress and migraine.
The research by the University of Calgary and...
Covid immunity lasts for many months, says study of healthcare workers
In a relief to healthcare workers who put their lives under risk while treating those with Covid-19, new findings from a study of thousands...
Codagenix, Serum Institute of India start first-in-human trial of Covid-19 vaccine
Codagenix, Inc., and the Serum Institute of India Pvt. Ltd. (SIIPL) have announced that a Phase 1 clinical trial of COVI-VAC received regulatory approval...
